Save to Existing Project
Save to a New Project
The first association chondroitin / glucosamine authorized as drug in Europe.
Droglican┬« is the first and only association chondroitin-glucosamine authorized as drug in Europe.
Indicated for the symptomatic treatment of osteoarthritis of the knee in patients suffering from moderate to severe pain due to osteoarthritis.
Authorized and commercialized in Spain.
Currently under registration in several countries of Europe. Available for out-licensing.
Type of Business Relationship Sought
Last Updated Mar 2017
REGISTERED / FINISHED PRODUCT